Efficacy of transcatheter arterial chemoembolization combined with sirolimus for treating Kasabach–Merritt phenomenon in infants, a retrospective study

References

• Kasabach HH, Merritt KK. Capillary hemangioma with extensive purpura: report of a case. Arch Pediatr Adolesc Med. 1940;59:1–8.
   Google Scholar
• Kwok-Williams M, Perez Z, Squire R, et al. Radiotherapy for life-threatening mediastinal haemangioma with kasabach-merritt syndrome. Pediatr Blood Cancer. 2007;49(5):739–744.
   PubMed Web of Science ®Google Scholar
• Wang Y, Wang S, Wang L, et al. Transarterial embolization in neonatal Kasabach-Merritt syndrome. Front Pediatr. 2021;9:788120.
   PubMed Web of Science ®Google Scholar
• Brill R, Uller W, Huf V, et al. Additive value of transarterial embolization to systemic sirolimus treatment in aposiform hemangioendothelioma. Int J Cancer. 2021;148(9):2345–2351.
   PubMed Web of Science ®Google Scholar
• Freixo C, Ferreira V, Martins J, et al. Efficacy and safety of sirolimus in the treatment of vasculKar anomalies: a systematic review. J Vasc Surg. 2020;71(1):318–327.
   PubMed Web of Science ®Google Scholar
• Sakata N, Suenobu SI, Okano M, et al. Impact of sirolimus treatment for refractory Kaposiform hemangioendothelioma with exacerbation of the disease 10 years after initial diagnosis. Rare Tumors. 2018;10: 2036361318776185.
   Google Scholar
• Blatt J, Stavas J, Moats-Staats B, et al. Treatment of childhood Kaposiform hemangioendothelioma with sirolimus. Pediatr Blood Cancer. 2010;55(7):1396–1398.
   PubMed Web of Science ®Google Scholar
• Wang Y, Kong L, Sun B, et al. Sirolimus for Kaposiform hemangioendothelioma with Kasabach-Merritt phenomenon in two infants. J Craniofac Surg. 2020;31(4):1074–1077.
   PubMed Web of Science ®Google Scholar
• MacFarland SP, Sullivan LM, States LJ, et al. Management of refractory pediatric Kaposiform hemangioendothelioma with sirolimus and aspirin. J Pediatr Hematol Oncol. 2018;40(4):e239–e242.
   PubMed Web of Science ®Google Scholar
• Mariani LG, Schmitt IR, Garcia CD, et al. Low dose sirolimus treatment for refractory tufted angioma and congenital Kaposiform hemangioendothelioma, both with Kasabach-Merritt phenomenon. Pediatr Blood Cancer. 2019;66(8):e27810.
   PubMed Web of Science ®Google Scholar
• Cashell J, Smink GM, Helm K, et al. Kaposiform hemangioendothelioma with Kasabach-Merritt phenomenon in an infant: successful treatment with prednisolone, vincristine, and addition of sirolimus. Pediatr Blood Cancer. 2018;65(12):e27305.
   PubMed Web of Science ®Google Scholar
• Jahnel J, Lackner H, Reiterer F, et al. Kaposiform hemangioendothelioma with Kasabach-Merritt phenomenon: from vincristine to sirolimus. Klin Padiatr. 2012;224(6):395–397.
   PubMed Web of Science ®Google Scholar
• Ji Y, Chen S, Xiang B, et al. Sirolimus for the treatment of progressive Kaposiform hemangioendothelioma: a multicenter retrospective study. Int J Cancer. 2017;141(4):848–855.
   PubMed Web of Science ®Google Scholar
• Wang H, Guo X, Duan Y, et al. Sirolimus as initial therapy for Kaposiform hemangioendothelioma and tufted angioma. Pediatr Dermatol. 2018;35(5):635–638.
   PubMed Web of Science ®Google Scholar
• Peng S, Yang K, Xu Z, et al. Vincristine and sirolimus in the treatment of Kaposiform haemangioendothelioma. J Paediatr Child Health. 2019;55(9):1119–1124.
   PubMed Web of Science ®Google Scholar
• Liu XH, Li JY, Qu XH, et al. Treatment of kaposiform hemangioendothelioma and tufted angioma. Int J Cancer. 2016;139(7):1658–1666.
   PubMed Web of Science ®Google Scholar
• Ying H, Qiao C, Yang X, et al. A case report of 2 sirolimus-related deaths among infants with kaposiform hemangioendotheliomas. Pediatrics. 2018;141(Suppl 5):S425–S429.
   PubMedGoogle Scholar
• Labonnelie A, Soupre V, Maruani A, et al. Management of sirolimus treatment for tumours associated with Kasabach-Merritt phenomenon. Acad Dermatol Venereol. 2022;36(7):e586–e588.
   PubMed Web of Science ®Google Scholar
• Cabrera TB, Speer AL, Greives MR, et al. Sirolimus for Kaposiform hemangioendothelioma and Kasabach-Merritt phenomenon in a neonate. AJP Rep. 2020;10(4):e390–e394.
   PubMedGoogle Scholar
• Argenta LC, Bishop E, Cho KJ, et al. Complete resolution of life-threatening hemangioma by embolization and corticosteroids. Plast Reconstr Surg. 1982;70(6):739–744.
   PubMed Web of Science ®Google Scholar
• Yesudian PD, Klafkowski J, Parslew R, et al. Tufted angioma-associated Kasabach-Merritt syndrome treated with embolization and vincristine. Plast Reconstr Surg. 2007;119(4):1392–1393.
   PubMed Web of Science ®Google Scholar
• O’Regan GM, Irvine AD, Yao N, et al. Mediastinal and neck Kaposiform hemangioendothelioma: report of three cases. Pediatr Dermatol. 2009;26(3):331–337.
   PubMed Web of Science ®Google Scholar
• Ryan C, Price V, John P, et al. Kasabach-Merritt phenomenon: a single centre experience. Eur J Haematol. 2010;84(2):97–104.
   PubMed Web of Science ®Google Scholar
• Garcia-Monaco R, Giachetti A, Peralta O, et al. Kaposiform hemangioendothelioma with Kasabach-Merritt phenomenon: successful treatment with embolization and vincristine in two newborns. J Vasc Interv Radiol. 2012;23(3):417–422.
   PubMed Web of Science ®Google Scholar
• Yuan SM, Hong ZJ, Chen HN, et al. Kaposiform hemangioendothelioma complicated by Kasabach-Merritt phenomenon: ultrastructural observation and immunohistochemistry staining reveal the trapping of blood components. Ultrastruct Pathol. 2013;37(6):452–455.
   PubMed Web of Science ®Google Scholar
• Khant ZA, Hirai T, Ikeda O, et al. Successful transarterial embolization with cellulose porous beads for occipital haemangioma in an infant with Kasabach-Merritt syndrome. BJR Case Reports. 2017;3(3):20170004.
   Google Scholar
• Zhou SY, Li HB, Mao YM, et al. Successful treatment of Kasabach-Merritt syndrome with transarterial embolization and corticosteroids. J Pediatr Surg. 2013;48(3):673–676.
   PubMed Web of Science ®Google Scholar
• Wang P, Zhou W, Tao L, et al. Clinical analysis of Kasabach-Merritt syndrome in 17 neonates. BMC Pediatr. 2014;14:146.
   PubMed Web of Science ®Google Scholar
• Tan X, Chen M, Zhang J, et al. Treatment of corticosteroid-resistant vascular tumors associated with the Kasabach-Merritt phenomenon in infants: an approach with transcatheter arterial embolization plus vincristine therapy. J Vasc Interv Radiol. 2016;27(4):569–575.
   PubMed Web of Science ®Google Scholar
• Leong E, Bydder S. Use of radiotherapy to treat life-threatening Kasabach-Merritt syndrome. J Med Imaging Radiat Oncol. 2009;53(1):87–91.
   PubMed Web of Science ®Google Scholar